United States — MedlinePlus
Tracked across 5 events · 68 articles · First seen May 23, 2025 · Last active Aug 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: United States — MedlinePlus is participating in two investor conferences, providing an opportunity to present its business and financial performance to investors, potentially increasing investor interest and confidence.
May 27, 2026 · 6 articles
Business
Impact: United States — MedlinePlus is expanding its manufacturing capacity in Slovakia, which is expected to support its future growth in Europe, strengthen supply chain resilience, and create new employment opportunities. This strategic investment reinforces its commitment to operational excellence and customer proximity.
Jun 08, 2026 · 6 articles
Accidents
Impact: United States — MedlinePlus's distribution center in United States — Tracy, California, was destroyed by fire, causing significant disruption to its operations and potential losses of medical supplies. The company is coordinating with authorities to assess the impact.
Jun 11, 2026 · 29 articles
Regulatory
Impact: Medline is the subject of the investigation and FDA warning; its stock lost $2.2 billion in market cap and faces potential legal liabilities.
Jul 01, 2026 · 6 articles
Regulatory
Medline Inc. (NASDAQ: MDLN) received a second FDA warning letter in two months, dated May 28, 2026 and published June 2, 2026, citing significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals, including…
Impact: Medline is the subject of FDA warning letters and securities investigations, with its stock dropping over 7% and 12% on separate occasions, and it faces potential legal liabilities and reputational damage.
Jul 15, 2026 · 21 articles
100
United States — Food and Drug Administration issued warning letter United States — MedlinePlusMedline FDA violations...
85
United States — MedlinePlus reported Q2 resultsMedline FDA violations...
70
Kessler Topaz Meltzer & Check launched investigation United States — MedlinePlusMedline FDA violations...
50
Kaplan Fox & Kilsheimer investigating potential violations United States — MedlinePlusMedline FDA violations...
ERGEN INTELLIGENCE
Track United States — MedlinePlus live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard